TRIGO-GROUP
15.5.2019 10:02:07 CEST | Business Wire | Press release
TRIGO Group, a global leader of quality solutions for the transportation industry has acquired EMC Consulting, a top Romanian quality training company. By combining expertise, the merge aims to spear-head quality improvements for customers’ production processes.
TRIGO has served more than 8,000 customers over the past 22 years worldwide. Over the past 12 years, EMC Consulting has served over 50 multinational companies in Romania. Our partnership enables EMC Consulting to extend its market reach beyond Romania to more than 25 countries serviced by TRIGO. In addition, TRIGO’s experience is further enhanced by EMC Consulting’s extensive training portfolio and local expertise.
EMC Consulting is highly regarded within the manufacturing market. They have trained more than 5,000 people in 35 training courses, covering both theoretical and practical quality knowledge including manufacturing, logistics, continuous improvement, and project management. Their client portfolio includes key players in the automotive industry, such as IRUM, Continental, and Adient.
Ovidiu Veghes, Country Manager for TRIGO Romania, worked closely in finalizing the acquisition. He stated, “EMC Consulting fits perfectly with our service portfolio. Our customer collaborations will be further strengthened.”
Constantin Pătășanu, CEO of EMC Consulting, said, “I am convinced that our common goals will speed up our development. I am excited to utilize our quality knowledge with TRIGO and offer more diverse services made up of training and consultancy aspects.”
Zsolt Puskás, EVP of the TREQ division which oversees training and consultancy operations for TRIGO, commented, “EMC Consulting distinguishes itself by going beyond standard quality requirements, providing solutions that embrace adaptability and creativity. They are a proven group of experts improving the effectiveness of production.”
About EMC Consulting
Founded in 2007, EMC Consulting is a training and consulting company with certified trainers and consultants according to IATF, ISO, VDA, REFA, and PMI. Their portfolio includes topics like lean manufacturing, lean six sigma, process engineering and logistics management. They support organizations in finding simple, creative, and customized quality solutions. Visit: https://emctm.ro
About TRIGO Group
Founded in 1997, TRIGO Group is a Global Quality Solutions provider for the transportation sector, focused on automotive and aerospace industries. With more than 10,000 professionals present in 25 countries, TRIGO offers a comprehensive portfolio of services including quality engineering, rework, inspection, auditing, training, consulting, and project management. Visit: https://trigo-group.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190515005054/en/
Contact:
Elaine Regas EVP, Global Sales & Marketing elaine.regas@trigo-group.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom